نتایج جستجو برای: mesalazine

تعداد نتایج: 692  

Crocin, as a carotenoid compound of saffron, exerts a potent antioxidant property. Mesalazine is frequently used in the treatment of ulcerative colitis. This study investigated the effects of separated and combination treatments with crocin and mesalazine in a rat model of ulcerative colitis. Ulcerative colitis was induced by intra-colonic administration of acetic acid (4.00%, 1.00 mL) at 8 cm ...

Journal: :Intestinal research 2017
Haruhiko Ogata Akihiro Ohori Haruo Nishino Seiichi Mizushima Atsushi Hagino Toshifumi Hibi

BACKGROUND/AIMS This study compared the efficacy of once-daily administration of multimatrix mesalazine 2.4 g/day with multiple-dose mesalazine for the maintenance of remission. METHODS In this multicenter, randomized, double-blind study, 203 patients with ulcerative colitis in remission received multimatrix mesalazine 2.4 g/day once-daily or time-dependent (controlled-release) mesalazine 2.2...

Journal: :The Netherlands journal of medicine 2012
M P Connolly C Boersma B Oldenburg

BACKGROUND In this study we investigate the costs and benefits of topical mesalazine combined with oral mesalazine therapy for active ulcerative colitis (UC), and once daily (OD ) mesalazine 2 grams versus twice daily (BID ) for maintaining UC remission. METHODS Two decision analytic models were constructed to evaluate treatment costs and quality-adjusted life years (QALYs) associated with me...

2017
W Kruis V Kardalinos T Eisenbach M Lukas T Vich I Bunganic J Pokrotnieks J Derova J Kondrackiene R Safadi D Tuculanu Z Tulassay J Banai A Curtin A E Dorofeyev S F Zakko N Ferreira S Björck M M Diez Alonso J Mäkelä N J Talley K Dilger R Greinwald R Mohrbacher R Spiller

BACKGROUND Previous studies have reached conflicting conclusions regarding the efficacy of mesalazine in the prevention of recurrent diverticulitis. AIM To investigate the efficacy and safety of mesalazine granules in the prevention of recurrence of diverticulitis after acute uncomplicated diverticulitis. METHODS Two phase 3, randomised, placebo-controlled, double-blind multicentre trials (...

2006
S A RILEY V MANI M J GOODMAN M E HERD S DUTT L A TURNBERG

Oral formulations of 5-aminosalicylic acid (mesalazine) appear less toxic than sulphasalazine. We have therefore compared sulphasalazine, low dose mesalazine and high dose mesalazine in the treatment of mild to moderate relapse of ulcerative colitis. Sixty one patients (32 men, aged 20-78 years) were randomly allocated to sulphasalazine 2 g daily, mesalazine 800 mg daily, or mesalazine 2.4 g da...

Journal: :Intestinal research 2017
Haruhiko Ogata Nobuo Aoyama Seiichi Mizushima Atsushi Hagino Toshifumi Hibi

BACKGROUND/AIMS This study assessed the efficacy and safety of high-dose multimatrix mesalazine once-daily (QD) compared to another form of high-dose mesalazine. METHODS In this multicenter, randomized, double-blind study, 280 patients with mildly to moderately active ulcerative colitis (UC) received multimatrix mesalazine 4.8 g/day QD or pH-dependent-release mesalazine 3.6 g/day three times ...

2016
Yunjian Zhang Ling Luo Xiaofang Wang Xiaoyang Liu Xiaoyan Wang Yi Ding

Mesalazine-induced eosinophilic pneumonia has been rarely reported. We reported a case of mesalazine-induced eosinophilic pneumonia in a 56-year-old female who took mesalazine without a prescription for suspected ulcerative colitis. She had an elevated eosinophil count in peripheral blood and bronchoalveolar lavage fluid. Eosinophil infiltration was also noted in bone marrow aspirates. Chest ra...

2009
Kevin C Cronin Gabrielle C Colleran Andrew Smyth Diarmuid D Houlihan Thomas A O’Gorman

A 32-year-old male presented with diarrhoea, mucus and bleeding per rectum. On the basis of sigmoidoscopy, rectal mesalazine was commenced uneventfully, and subsequently changed to oral mesalazine due to failure to improve.He re-presented 4 days later with frequent rigors, lethargy, palpitations and was generally unwell. His condition settled with conservative management and IV antibiotics.Oral...

Journal: :Gut 1988
S A Riley V Mani M J Goodman M E Herd S Dutt L A Turnberg

Oral formulations of 5-aminosalicylic acid (mesalazine) appear less toxic than sulphasalazine. We have therefore compared sulphasalazine, low dose mesalazine and high dose mesalazine in the treatment of mild to moderate relapse of ulcerative colitis. Sixty one patients (32 men, aged 20-78 years) were randomly allocated to sulphasalazine 2 g daily, mesalazine 800 mg daily, or mesalazine 2.4 g da...

2015
Satohiro Matsumoto Yukio Yoshida

BACKGROUND We conducted a retrospective cohort study to clinically and endoscopically assess the efficacy of delayed-release mesalazine for ulcerative colitis. METHODS The study included 104 ulcerative colitis patients (52 men, 52 women) initiated on treatment with delayed-release mesalazine between 2009 and 2012. The clinical symptoms at months 0, 1, and 12 were scored using the clinical act...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید